Role of oxidative stress in acute liver injury

Corresponding author: LUO Yawen, luoyw719@163.com(ORCID: 0000-0002-8845-1265)
Received Date: 2022-02-27
Accepted Date: 2022-04-02
Published Date: 2022-10-20

Abstract

Abstract

Acute liver injury (ALI) is often caused by virus infection, alcohol, drugs, toxin, and metabolic disorder, and oxidative stress is a common pathophysiological mechanism in the development and progression of ALI and other liver diseases. Hepatocyte function is impaired after ALI, which further causes oxidative stress, and persistent or high-intensive oxidative stress may increase the risk of hepatocyte death and thus result in a series of liver diseases. Oxidative stress is mainly associated with the signaling pathways including nuclear factor erythroid 2-related factor 2 and nuclear factor-kappa B. Therefore, it is of great importance to understand the mechanism of oxidative stress in the development and progression of liver injury and related pathways. This article introduces oxidative system and antioxidative system, oxidative stress and damage factors, and oxidative stress and pathways associated with liver injury, so as to provide a reference for the selection of therapeutic targets for ALI and related clinical research.
- Acute Liver Injury,
- Oxidative Stress,
- NF-E2-Related Factor 2,
- NF-kappa B

FullText(HTML)

References(45)

References

[1]	SHRESTHA DB, BUDHATHOKI P, SEDHAI YR, et al., N-acetyl cysteine versus standard of care for non-acetaminophen induced acute liver injury: a systematic review and meta-analysis[J]. Ann Hepatol, 2021, 24: 100340. DOI: 10.1016/j.aohep.2021.100340.
[2]	XU FL, XU JX, XIONG X, et al. Salidroside inhibits MAPK, NF-kappaB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation[J]. Redox Rep, 2019, 24(1): 70-74. DOI: 10.1080/13510002.2019.1658377.
[3]	SEEN S. Chronic liver disease and oxidative stress-a narrative review[J]. Expert Rev Gastroenterol Hepatol, 2021, 15(9): 1021-1035. DOI: 10.1080/17474124.2021.1949289.
[4]	ZHONG X, ZHANG Z, SHEN H, et al. Hepatic NF-κB-inducing kinase and inhibitor of NF-κB kinase subunit α promote liver oxidative stress, ferroptosis, and liver injury[J]. Hepatol Commun, 2021, 5(10): 1704-1720. DOI: 10.1002/hep4.1757.
[5]	SINGH A, KUKRETI R, SASO L, et al. Oxidative stress: a key modulator in neurodegenerative diseases[J]. Molecules, 2019, 24(8): 1583. DOI: 10.3390/molecules24081583.
[6]	FOO BJ, EU JQ, HIRPARA JL, et al. Interplay between mitochondrial metabolism and cellular redox state dictates cancer cell survival[J]. Oxid Med Cell Longev, 2021, 2021: 1341604. DOI: 10.1155/2021/1341604.
[7]	HAJAM YA, RANI R, GANIE SY, et al. Oxidative stress in human pathology and aging: molecular mechanisms and perspectives[J]. Cells, 2022, 11(3): 552. DOI: 10.3390/cells11030552.
[8]	JUAN CA, PÉREZ DE LA LASTRA JM, PLOU FJ, et al. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies[J]. Int J Mol Sci, 2021, 22(9): 4642. DOI: 10.3390/ijms22094642.
[9]	NOLFI-DONEGAN D, BRAGANZA A, SHIVA S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement[J]. Redox Biol, 2020, 37: 101674. DOI: 10.1016/j.redox.2020.101674.
[10]	VALLEJO FA, VANNI S, GRAHAM RM. UCP2 as a potential biomarker for adjunctive metabolic therapies in tumor management[J]. Front Oncol, 2021, 11: 640720. DOI: 10.3389/fonc.2021.640720.
[11]	YING JF, LU ZB, FU LQ, et al. The role of iron homeostasis and iron-mediated ROS in cancer[J]. Am J Cancer Res, 2021, 11(5): 1895-1912.
[12]	ZHANG Z, RONG L, LI YP. Flaviviridae viruses and oxidative stress: implications for viral pathogenesis[J]. Oxid Med Cell Longev, 2019, 2019: 1409582. DOI: 10.1155/2019/1409582.
[13]	TANIMIZU N, ICHINOHE N, SUZUKI H, et al. Prolonged oxidative stress and delayed tissue repair exacerbate acetaminophen-induced liver injury in aged mice[J]. Aging (Albany NY), 2020, 12(19): 18907-18927. DOI: 10.18632/aging.103973.
[14]	TODOROVI C ' VUKOTI C ' N, -DOR-DEVI C ' J, PEJI C ' S, et al. Antidepressants-and antipsychotics-induced hepatotoxicity[J]. Arch Toxicol, 2021, 95(3): 767-789. DOI: 10.1007/s00204-020-02963-4.
[15]	HAN H, DESERT R, DAS S, et al. Danger signals in liver injury and restoration of homeostasis[J]. J Hepatol, 2020, 73(4): 933-951. DOI: 10.1016/j.jhep.2020.04.033.
[16]	FAN X, LIN L, CUI B, et al. Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe[J]. Pharmacol Res, 2020, 159: 104945. DOI: 10.1016/j.phrs.2020.104945.
[17]	DUYGU F, KARSEN H, AKSOY N, et al. Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis[J]. Ann Lab Med, 2012, 32(2): 113-118. DOI: 10.3343/alm.2012.32.2.113.
[18]	XIANYU J, FENG J, YANG Y, et al. Correlation of oxidative stress in patients with HBV-induced liver disease with HBV genotypes and drug resistance mutations[J]. Clin Biochem, 2018, 55: 21-27. DOI: 10.1016/j.clinbiochem.2018.03.014.
[19]	HERRSCHER C, ROINGEARD P, BLANCHARD E. Hepatitis B virus entry into cells[J]. Cells, 2020, 9(6): 1486. DOI: 10.3390/cells9061486.
[20]	ALMAEEN AH, ALDURAYWISH AA, MOBASHER MA, et al. Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients[J]. Arch Med Sci, 2021, 17(2): 368-375. DOI: 10.5114/aoms.2019.91451.
[21]	SOBHANIMONFARED F, BAMDAD T, ROOHVAND F. Cross talk between alcohol-induced oxidative stress and HCV replication[J]. Arch Microbiol, 2020, 202(7): 1889-1898. DOI: 10.1007/s00203-020-01909-9.
[22]	GRAVIER-HERNÁNDEZ R, GIL-DEL VALLE L, VALDES-ALONSO L, et al. Oxidative stress in hepatitis C virus-human immunodeficiency virus co-infected patients[J]. Ann Hepatol, 2020, 19(1): 92-98. DOI: 10.1016/j.aohep.2019.05.009.
[23]	RAMÍREZ A, VÁZQUEZ-SÁNCHEZ AY, CARRIÓN-ROBALINO N, et al. Ion channels and oxidative stress as a potential link for the diagnosis or treatment of liver diseases[J]. Oxid Med Cell Longev, 2016, 2016: 3928714. DOI: 10.1155/2016/3928714.
[24]	GOU SH, HE M, LI BB, et al. Hepatoprotective effect of total flavonoids from Glycyrrhiza uralensis Fisch in liver injury mice[J]. Nat Prod Res, 2021, 35(24): 6083-6087. DOI: 10.1080/14786419.2020.1824223.
[25]	TAN HK, YATES E, LILLY K, et al. Oxidative stress in alcohol-related liver disease[J]. World J Hepatol, 2020, 12(7): 332-349. DOI: 10.4254/wjh.v12.i7.332.
[26]	WAN YM, WU HM, LI YH, et al. Corrigendum: TSG-6 inhibits oxidative stress and induces M2 polarization of hepatic macrophages in mice with alcoholic hepatitis via suppression of STAT3 activation[J]. Front Pharmacol, 2020, 11: 569. DOI: 10.3389/fphar.2020.00569.
[27]	HSU MF, KOIKE S, MELLO A, et al. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice[J]. Redox Biol, 2020, 36: 101658. DOI: 10.1016/j.redox.2020.101658.
[28]	DONATO M, TOLOSA L. High-content screening for the detection of drug-induced oxidative stress in liver cells[J]. Antioxidants (Basel), 2021, 10(1): 106. DOI: 10.3390/antiox10010106.
[29]	GHANIM BY, AHMAD MI, ABDALLAH QM, et al. Modulation of NRF2/ARE pathway-and cell death-related genes during drug-induced liver injury[J]. Hum Exp Toxicol, 2021, 40(12): 2223-2236. DOI: 10.1177/09603271211027947.
[30]	VILLANUEVA-PAZ M, MORÁN L, LÓPEZ-ALCÁNTARA N, et al. Oxidative stress in drug-induced liver injury (DILI): From mechanisms to biomarkers for use in clinical practice[J]. Antioxidants (Basel), 2021, 10(3): 390. DOI: 10.3390/antiox10030390.
[31]	UNSAL V, CICEK M, SABANCILAR I ·. Toxicity of carbon tetrachloride, free radicals and role of antioxidants[J]. Rev Environ Health, 2021, 36(2): 279-295. DOI: 10.1515/reveh-2020-0048.
[32]	EZHILARASAN D, RAGHUNANDHAKUMAR S. Boldine treatment protects acetaminophen-induced liver inflammation and acute hepatic necrosis in mice[J]. J Biochem Mol Toxicol, 2021, 35(4): e22697. DOI: 10.1002/jbt.22697.
[33]	XU D, XU M, JEONG S, et al. The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches[J]. Front Pharmacol, 2018, 9: 1428. DOI: 10.3389/fphar.2018.01428.
[34]	YI G, DIN JU, ZHAO F, et al. Effect of soybean peptides against hydrogen peroxide induced oxidative stress in HepG2 cells via Nrf2 signaling[J]. Food Funct, 2020, 11(3): 2725-2737. DOI: 10.1039/c9fo01466g.
[35]	SENTHIL KUMAR KJ, LIAO JW, XIAO JH, et al. Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes[J]. Toxicol In Vitro, 2012, 26(5): 700-708. DOI: 10.1016/j.tiv.2012.03.012.
[36]	GONG P, CEDERBAUM AI. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1[J]. Hepatology, 2006, 43(1): 144-153. DOI: 10.1002/hep.21004.
[37]	YU Z, YANG L, DENG S, et al. Daidzein ameliorates LPS-induced hepatocyte injury by inhibiting inflammation and oxidative stress[J]. Eur J Pharmacol, 2020, 885: 173399. DOI: 10.1016/j.ejphar.2020.173399.
[38]	LV H, ZHU C, WEI W, et al. Enhanced Keap1-Nrf2/Trx-1 axis by daphnetin protects against oxidative stress-driven hepatotoxicity via inhibiting ASK1/JNK and Txnip/NLRP3 inflammasome activation[J]. Phytomedicine, 2020, 71: 153241. DOI: 10.1016/j.phymed.2020.153241.
[39]	HU J, ZHU Z, YING H, et al. Oleoylethanolamide protects against acute liver injury by regulating Nrf-2/HO-1 and NLRP3 pathways in mice[J]. Front Pharmacol, 2020, 11: 605065. DOI: 10.3389/fphar.2020.605065.
[40]	MITCHELL S, VARGAS J, HOFFMANN A. Signaling via the NF-κB system[J]. Wiley Interdiscip Rev Syst Biol Med, 2016, 8(3): 227-241. DOI: 10.1002/wsbm.1331.
[41]	LONG X, SONG J, ZHAO X, et al. Silkworm pupa oil attenuates acetaminophen-induced acute liver injury by inhibiting oxidative stress-mediated NF-κB signaling[J]. Food Sci Nutr, 2020, 8(1): 237-245. DOI: 10.1002/fsn3.1296.
[42]	WANG M, NIU J, OU L, et al. Zerumbone protects against carbon tetrachloride (CCl₄)-induced acute liver injury in mice via inhibiting oxidative stress and the inflammatory response: involving the TLR4/NF-κB/COX-2 pathway[J]. Molecules, 2019, 24(10): 1964. DOI: 10.3390/molecules24101964.
[43]	LI R, YANG W, YIN Y, et al. Protective Role of 4-Octyl itaconate in murine LPS/D-GalN-induced acute liver failure via inhibiting inflammation, oxidative stress, and apoptosis[J]. Oxid Med Cell Longev, 2021, 2021: 9932099. DOI: 10.1155/2021/9932099.
[44]	ZHANG L, MENG B, LI L, et al. Boletus aereus protects against acute alcohol-induced liver damage in the C57BL/6 mouse via regulating the oxidative stress-mediated NF-κB pathway[J]. Pharm Biol, 2020, 58(1): 905-914. DOI: 10.1080/13880209.2020.1812672.
[45]	LIU Z, WANG X, LI L, et al. Hydrogen sulfide protects against paraquat-induced acute liver injury in rats by regulating oxidative stress, mitochondrial function, and inflammation[J]. Oxid Med Cell Longev, 2020, 2020: 6325378. DOI: 10.1155/2020/6325378.

Relative Articles

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	蔡纲，高庆娥，史元建. 富马酸替诺福韦酯和富马酸丙酚替诺福韦序贯联合聚乙二醇干扰素α-2b治疗慢性乙型肝炎患者的疗效比较. 黑龙江医药科学. 2024(01): 154-157 .
2.	庄辉. 慢性乙型肝炎：从"只治"到"全治". 中华肝脏病杂志. 2024(05): 389-393 .
3.	曾达武，朱月永. 非活动性HBsAg携带状态抗病毒治疗的利与弊. 临床内科杂志. 2023(12): 802-806 .
4.	曾达武，朱月永. 非活动性乙型肝炎病毒表面抗原携带者的治疗. 国际流行病学传染病学杂志. 2022(04): 225-231 .
5.	郑慧珂，孙昳，温瑾. 干扰素与核苷(酸)类似物对慢性乙型肝炎患者外周血调节性T细胞水平的影响. 中国实用医刊. 2021(04): 101-103 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3)

Get Citation

PDF

XML

Article Metrics

Article views (1707) PDF downloads(230)

Role of oxidative stress in acute liver injury

DOI: 10.3969/j.issn.1001-5256.2022.10.039

Abstract

References

Cited by

Periodical cited type(5)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content